X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (22) 22
cardiac & cardiovascular systems (15) 15
index medicus (15) 15
abridged index medicus (14) 14
cardiology and cardiovascular medicine (14) 14
heart attacks (14) 14
humans (13) 13
internal medicine (13) 13
stents (11) 11
cardiology (10) 10
female (10) 10
male (10) 10
acute coronary syndromes (9) 9
aged (9) 9
cardiac patients (9) 9
clinical trials (9) 9
mortality (9) 9
coronary vessels (8) 8
middle aged (8) 8
patients (8) 8
thrombosis (8) 8
care and treatment (7) 7
implantation (7) 7
stent (7) 7
stroke (7) 7
anticoagulants (6) 6
aspirin (6) 6
bleeding (6) 6
clinical outcomes (6) 6
clopidogrel (6) 6
definitions (6) 6
intervention (6) 6
treatment outcome (6) 6
acute myocardial-infarction (5) 5
cardiovascular disease (5) 5
coronary heart disease (5) 5
medical colleges (5) 5
medicine, general & internal (5) 5
myocardial infarction (5) 5
randomization (5) 5
safety (5) 5
therapy (5) 5
bare-metal stent (4) 4
consortia (4) 4
coronary angiography (4) 4
coronary artery (4) 4
coronary artery disease (4) 4
drug therapy (4) 4
drug-eluting stent (4) 4
drug-eluting stents (4) 4
dual-antiplatelet therapy (4) 4
heart diseases (4) 4
medical research (4) 4
medicine, experimental (4) 4
metaanalysis (4) 4
myocardial-infarction (4) 4
outcomes (4) 4
percutaneous coronary intervention (4) 4
percutaneous coronary intervention - adverse effects (4) 4
percutaneous coronary intervention - methods (4) 4
platelet aggregation inhibitors - administration & dosage (4) 4
randomized-trial (4) 4
risk assessment (4) 4
sects (4) 4
st-segment elevation (4) 4
studies (4) 4
ticlopidine - analogs & derivatives (4) 4
time factors (4) 4
analysis (3) 3
angioplasty (3) 3
aspirin - administration & dosage (3) 3
atrial fibrillation (3) 3
cardiac arrhythmia (3) 3
clinical-trials (3) 3
coronary artery bypass (3) 3
coronary artery disease - surgery (3) 3
coronary artery disease - therapy (3) 3
drug therapy, combination (3) 3
drug-eluting stents - adverse effects (3) 3
dual antiplatelet therapy (3) 3
duration (3) 3
electrocardiography (3) 3
follow-up (3) 3
heart (3) 3
heart attack (3) 3
heart failure (3) 3
implants (3) 3
infarction (3) 3
ischemia (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
motivation (3) 3
sirolimus - administration & dosage (3) 3
sirolimus - analogs & derivatives (3) 3
sirolimus-eluting stent (3) 3
surgical implants (3) 3
thromboembolism (3) 3
ticlopidine - administration & dosage (3) 3
transluminal angioplasty (3) 3
zotarolimus-eluting stent (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | OPTICAL COHERENCE TOMOGRAPHY | RANDOMIZED-TRIAL | IMPLANTATION | POLYMER | ACUTE MYOCARDIAL-INFARCTION | CORONARY-ARTERY STENTS | ST-SEGMENT ELEVATION | DURATION | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 7, pp. 742 - 753
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 95 - 102
Background Proton pump inhibitors (PPIs) are frequently prescribed in combination with clopidogrel, but conflicting data exist as to whether PPIs diminish the... 
Cardiovascular | LANSOPRAZOLE | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | CARDIOVASCULAR EVENTS | PREVENTION | OMEPRAZOLE | Follow-Up Studies | Humans | Middle Aged | Male | Aspirin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Hyperplasia - drug therapy | Drug Therapy, Combination | Myocardial Infarction - diagnosis | Myocardial Infarction - surgery | Coronary Vessels - drug effects | Coronary Vessels - pathology | Administration, Oral | Treatment Outcome | Ticlopidine - analogs & derivatives | Hyperplasia - etiology | Hyperplasia - pathology | Tunica Intima - drug effects | Graft Occlusion, Vascular - etiology | Tunica Intima - pathology | Graft Occlusion, Vascular - pathology | Graft Occlusion, Vascular - drug therapy | Coronary Vessels - surgery | Aged | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Care and treatment | Cardiac patients | Patient outcomes | Clinical trials | Proton pump inhibitors | Stent (Surgery) | Studies | Consortia | Heart attacks | Coronary vessels | Classification | Prodigies | Metabolism | Multivariate analysis | Stents | Clinical outcomes
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 175, pp. 56 - 65
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 6, pp. 506 - 512
Objectives This study sought to investigate the clinical outcome of patients treated with percutaneous coronary intervention (PCI) for in-stent restenosis... 
Cardiovascular | Internal Medicine | dual antiplatelet therapy | clopidogrel | aspirin | drug eluting stent(s) | percutaneous coronary intervention | in-stent restenosis | Sects | Care and treatment | Cardiac patients | Stent (Surgery) | Heart attacks | Drug therapy | Angioplasty | Stents
Journal Article
American Heart Journal, ISSN 0002-8703, 02/2017, Volume 184, pp. 81 - 87
Optimal antithrombotic treatment after transcatheter aortic valve replacement (TAVR) is unknown and determined empirically. The direct factor Xa inhibitor... 
DEFINITIONS | EXPERT CONSENSUS DOCUMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | THERAPY | IMPLANTATION | CORONARY | THROMBOSIS | RISK | SOCIETY | Transcatheter Aortic Valve Replacement | Myocardial Infarction - epidemiology | Pulmonary Embolism - prevention & control | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Pulmonary Embolism - epidemiology | Cause of Death | Heart Valve Diseases - epidemiology | Cardiovascular Diseases - epidemiology | Stroke - epidemiology | Venous Thrombosis - prevention & control | Aortic Valve Stenosis - surgery | Aspirin - therapeutic use | Thrombosis - prevention & control | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Embolism - epidemiology | Rivaroxaban - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Mortality | Thrombosis - epidemiology | Postoperative Care - methods | Ticlopidine - analogs & derivatives | Factor Xa Inhibitors - therapeutic use | Heart Valve Diseases - prevention & control | Venous Thrombosis - epidemiology | Myocardial Infarction - prevention & control | Prevention | Clinical trials | Heart valve diseases | Pulmonary embolism | Aspirin | Atrial fibrillation | Anticoagulants (Medicine) | Thrombosis | Heart attack | Blood clot | Cardiac arrhythmia | Prostheses | Stroke | Bone surgery | Patients | Blood clots | Blood platelets | Orthopedics | Tomography | Acute coronary syndromes | Thromboembolism
Journal Article
American Heart Journal, ISSN 0002-8703, 03/2019, Volume 209, pp. 97 - 105
Journal Article